Unbiased and efficient estimation of causal treatment effects in crossover trials

DOI10.1002/BIMJ.202200170zbMATH Open1544.62341MaRDI QIDQ6595087FDOQ6595087

C. B. Pipper, Thomas H. Scheike, Jeppe Ekstrand Halkjær Madsen

Publication date: 29 August 2024

Published in: Biometrical Journal (Search for Journal in Brave)

zbMATH Keywords

causal inferencebiasefficiencycrossover trialsTQT studies

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Cites Work

• Semiparametric theory and missing data.
• A new approach to causal inference in mortality studies with a sustained exposure period—application to control of the healthy worker survivor effect
• Simultaneous Inference in General Parametric Models
• Linear and generalized linear mixed models and their applications.
• Title not available (Why is that?)
• Ethical considerations concerning treatment allocation in drug development trials
• Some Surprising Results about Covariate Adjustment in Logistic Regression Models
• Bioequivalence and statistics in clinical pharmacology.
• The use of baseline covariates in crossover studies
• Model-Robust Inference for Clinical Trials that Improve Precision by Stratified Randomization and Covariate Adjustment
• A versatile method for confirmatory evaluation of the effects of a covariate in multiple models
• Small-Sample Methods for Cluster-Robust Variance Estimation and Hypothesis Testing in Fixed Effects Models

This page was built for publication: Unbiased and efficient estimation of causal treatment effects in crossover trials

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6595087)